Quasar North America expansion

Announcement: Quasar Expands to North America with Commercial Headquarters in Minnetonka, Minnesota

Announcement: Quasar Expands to North America with Commercial Headquarters in Minnetonka, Minnesota

Quasar North America expansion

Quasar Medical Devices, LLC is pleased to announce the expansion of our North American Commercial Headquarters in Minnetonka, Minnesota. This expansion strengthens Quasar’s global presence, allowing for a continued focus on supporting North American customers. Located in one of the key medical device clusters, Quasar Medical Devices USA will bring additional commercial support to existing customers through new sales, business development and commercial staff.  “Expanding our global footprint to North America strengthens our commitment to support our current USA customers with direct staff, while positioning Quasar to service new customers with our unique capabilities and technologies” said Ayal Amitai, Quasar Medical president and CEO.


Schedule a Consultation with a Quasar Expert


In support of the expanded North American commercial operations, Quasar is pleased to announce the hiring of the following key personnel:

Alex Denogean joins Quasar as Vice President of Business Development with more than 30 years of medical device experience, having served in leadership roles at Baxter, Medtronic, Honeywell, Raydiance, Ametec and several privately held medical device design and contract manufacturing firms. Alex will lead the sales, business development and technical support based in Minneapolis, MN

Jyrki Calderon Larjanko joins Quasar as the North American Director of Key Accounts and Business Development based in San Diego, CA. Jyrki brings over 25 years of global medical device and industrial machining sector experience, having held various management roles including manufacturing management, technical services, sales and business development. Prior to joining Quasar, Jyrki held several management positions of increasing responsibility at Johnson Matthey’s medical business unit. Jyrki will lead onsite sales and business development support for Quasar’s strategic customers.

Sam Chaoui PhD, MEM, PE – joins Quasar as Principal Application Engineer. Sam brings over 35 years expertise in many medical fields such as Respiratory Care, Orthopedics and Ophthalmology. Sam held many progressive management roles at Bear Medical, Care Fusion, BD, Alcon, Össur and Salter Labs. Sam held positions in R&D, Regulatory, Quality and FDA support roles. Sam holds many patents and is often sought after as a medical device SME. Sam will provide technical support for all BD customers and strategic accounts from his base at Riverside, CA.

In addition to Quasar North America’s direct staff, Dennis Olson continues to support Quasar as an independent and well-established industry representative based in Minneapolis, MN. Dennis brings over 23 years of medical device experience having worked for Microvena, Accellent, Tegra, Cretex and CarTika in roles from R&D, Clinical, Sales and Operations. Dennis is a veteran of United States Air Force.

Quasar’s Israeli operations (QIL) headed by David Ben Shitrit, Global NPD & Technologies Director, will continue to support all global business development efforts. This ensures the development process follows a seamless product lifecycle while remaining customer-centric.

About Quasar:

Quasar Medical Devices LLC is the leading medical device outsource (MDO) manufacturer in micro-assemblies, minimally invasive devices, and medical disposables. The company provides innovative, high-quality technologies and manufacturing to Medical Device OEM’s that enable novel product designs across multiple therapy areas. With manufacturing locations in Shenzhen and Dongguan, China, and a newly opened manufacturing location in Chonburi, Thailand, Quasar offers OEMs low cost region manufacturing solutions at our FDA registered, ISO13485, and ISO 7 cleanroom facilities.

Contact Quasar’s US team today 

Read More

China MAH Policy

China MAH Policy Changes and The massive Opportunity for Medical Device OEMs

The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.

crisis leadership

The Impact of Quasar’s Crisis Leadership Through Covid-19

As rumors of Covid-19 spread in January 2020, and fear gripped most of China, the management had to face facts and realize that a serious crisis was in the offing. Instead of being paralyzed by fear and uncertainty, Quasar’s leadership headed by Ayal Amitai, CEO, began looking ahead, considering courses of action to get the plant working again.